ARTICLE | Finance
Nautilus raises $76M series B to deliver next-generation proteomics to the lab
May 22, 2020 12:29 AM UTC
Looking to elevate the proteome to the same level as the genome for biotech R&D, Nautilus raised $76 million in a series B led to bring its proteomics platform to market.
Vulcan Capital, the investment arm of Paul Allen’s Vulcan Inc., led the untranched round. Fellow new investors Perceptive Advisors, Bezos Expeditions and Defy Partners also participated, as did existing investors AME Cloud Ventures, Andreessen Horowitz, Bolt and Madrona Venture Group...
BCIQ Company Profiles